English Polski
Vol 15, No 1 (2018)
Review paper
Published online: 2018-03-28

open access

Page views 2356
Article views/downloads 15752
Get Citation

Connect on Social Media

Connect on Social Media

Sexual dysfunction in the course of depressive disorders

Michał Wróbel1, Anna Mosiołek21
Psychiatria 2018;15(1):39-44.

Abstract

Sexual dysfunctions are a significant part of the symptomatology of depression. Depression as well as sexual dysfunctions are a serious health issue of many people. They suffer not only due to the direct consequences of those disorders, but also because of their stigmatizing nature. Despite the available research, their interdependence as well as the correlation between appearing and resolution of sexual dysfunctions during anti-depressive pharmacotherapy remains unclear. The available research often focuses on individual aspects of the problem, assessing the relation between specific sexual dysfunctions and depression (sexual dysfunctions viewed as symptoms of depression) or the impact of anti-depressive therapy on sexual dysfunction incidence (sexual dysfunctions as adverse events of anti-depressive drugs). Some, on the other hand, generalize this subject while including sexual dysfunctions in broad assessments of depression symptomatology. One can observe a different constellation of individual dysfunctions depending on the phase of depression therapy. This report is meant to present some of the available research materials and help to organize this knowledge, as well as indicate multiple directions of further required explanations of the complex causal relations between sexual dysfunctions and depressive disorders.

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. ICD-10. Międzynarodowa Statystyczna Klasyfikacja Chorób i Problemów Zdrowotnych. Rewizja dziesiąta. Rozdział V: Zaburzenia psychiczne i zaburzenia zachowania (F00-F99). Wyd. Vesalius, Kraków 1994.
  2. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999; 281(6): 537–544.
  3. Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol. 1998; 13 Suppl 6: S1–S4.
  4. Seidman SN, Roose SP, Seidman SN, et al. The relationship between depression and erectile dysfunction. Curr Psychiatry Rep. 2000; 2(3): 201–205.
  5. Kiejna A, Rybakowski J, Dudek D. Psychiatryczne skale oceny w zaburzeniach afektywnych. Biblioteka Psychiatrii Polskiej Kraków. 2012: 56–68.
  6. Casper RC, Redmond DE, Katz MM, et al. Somatic symptoms in primary affective disorder. Presence and relationship to the classification of depression. Arch Gen Psychiatry. 1985; 42(11): 1098–1104.
  7. Kennedy SH, Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol. 2009; 29(2): 157–164.
  8. Higgins A, Nash M, Lynch AM. Antidepressant-associated sexual dysfunction: impact, effects, and treatment. Drug Healthc Patient Saf. 2010; 2: 141–150.
  9. Montejo-Gonzalez AL, Llorca G, Izquierdo JA, et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther. 1997; 23(3): 174–194.
  10. Gregorian RS, Golden KA, Bahce A, et al. Antidepressant-induced sexual dysfunction. Ann Pharmacother. 2002; 36(10): 1577–1589.
  11. Urząd Rejestracji Produktów leczniczych Wyrobów Medycznych i Produktów Biobójczych, Charakterystyki produktów leczniczych : Deprexolet, Lerivon, Miansec, Miansegen, Andepin, Bioxetin, Deprexetin, Fluoksetyna ANPHARM, Fluoxetin Polpharma, Seronil, Fluxemed. 2013. leki.urpl.gov.pl/index.php.
  12. Clayton AH, Montejo AL. Major depressive disorder, antidepressants, and sexual dysfunction. J Clin Psychiatry. 2006; 67 Suppl 6: 33–37.
  13. Landowski J. Patogeneza dysfunkcji seksualnych w depresji. Psych Prakt Ogólnolek. 2003; 3(1): 23–25.
  14. Jakima S, Lew-Starowicz M. Dysfunkcje seksualne w depresji. Wydawnictwo Most, Warszawa 2010.